Suchergebnisse - "Fever"

PubPharm (158)

1

bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease

enthalten in: Annals of the rheumatic diseases | 2024

von Kvacskay, P. | Hegenbart, U. | Lorenz, H. | +2

2

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders : Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

enthalten in: ClinicalTrials.gov | 2024

3

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders : Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

enthalten in: ClinicalTrials.gov | 2024

4

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies : A French Open-label Extension Study of Canakinumab in Patients Who Participated in International Phase III Studies CACZ885G2301E1 or CACZ885G2306 in Systemic Juvenile Idiopathic Arthritis and CACZ885N2301 in Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF)

enthalten in: ClinicalTrials.gov | 2020

5

Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) : Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)

enthalten in: ClinicalTrials.gov | 2018

6

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes : An Extension Study of CACZ885N2301 (NCT02059291), Multi-center, Open Label Study of Canakinumab in Japanese Patients With Periodic Fever Syndromes (Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS), Hyper Immunoglobulin D Syndrome ((Also Known as Mevalonate Kinase Deficiency) (HIDS/MKD), or Colchicine Resistant/Intolerant Familial Mediterranean Fever (crFMF))

enthalten in: ClinicalTrials.gov | 2018

7

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers : A Randomized, Double-blind, Placebo Controlled Study of Canakinumab in Patients With Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF), With Subsequent Randomized Withdrawal/Dosing Frequency Reduction and Open-label Long-term Treatment Epochs

enthalten in: ClinicalTrials.gov | 2018

8

Familial Mediterranean Fever in childhood: a single center experience

enthalten in: Pediatric rheumatology | 2015

von Barut, K. | Sinoplu, A. | Yucel, G. | +4

9

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?

enthalten in: Pediatric rheumatology | 2015

von Sargsyan, A. | Narimanyan, M.

10

Canakinumab therapy in patients with Familial Mediterranean Fever

enthalten in: Pediatric rheumatology | 2015

von Ugurlu, S. | Seyahi, E. | Hatemi, G. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]